Cost-Effectiveness Analysis of Bevacizumab plus Paclitaxel...

  • Main
  • 2020 / 3
  • Cost-Effectiveness Analysis of Bevacizumab plus Paclitaxel...

Cost-Effectiveness Analysis of Bevacizumab plus Paclitaxel versus Bevacizumab plus Capecitabine for HER2-Negative Locally Recurrent or Metastatic Breast Cancer

Wu, Qiuji, Wang, Xinyuan, Zhang, Mengxi, Liao, Weiting, Wang, Feng, Li, Qiu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Oncology Research and Treatment
DOI:
10.1159/000505932
Date:
March, 2020
File:
PDF, 221 KB
english, 2020
Conversion to is in progress
Conversion to is failed